ConductScience.org, home

Trial · NCT07883005

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of Major Adverse Dental Events (MADE)2 yearsMajor adverse dental events (MADE), defined as tooth failure and/or grade 2 or higher jaw osteoradionecrosis (ORN),
SecondaryIncidence of Tooth Failure1, 3, 6, 12, 24, 36 months post RTNumber or proportion of participants experiencing tooth failure using ClinRad ORN grading system
SecondarySeverity of Acute Radiation-Induced Oral Mucositis1 and 3 months post RT
Acute oral mucositis severity assessed using the World Health Organization (WHO) Oral Mucositis Grading Scale. Scores range from 0 to 4, where higher scores indicate worse oral mucositis severity (worse outcome).
SecondarySeverity of Acute Radiation-Induced Oral Mucositis1 and 3 months post RT
Acute oral mucositis severity assessed using Oral Mucositis Weekly Questionnaire (OMWQ), which evaluates symptoms such as mouth and throat soreness and difficulties with eating, drinking, swallowing, talking, and sleeping. Higher scores indicate more severe oral mucositis symptoms and greater functional impairment (worse outcome).
SecondaryPhysician-Assessed Treatment-Related Toxicities1, 3, 6, 12, 24, 36 months post RTIncidence and severity of treatment-related adverse events assessed using the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0.
SecondaryPatient-Reported Treatment-Related Toxicities12, 24 months post RTPatient-reported treatment-related adverse events assessed using the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Version 1.0.
SecondarySalivary Function1, 3, 6, 12, 24, 36 months post RTUnstimulated salivary flow rate assessed using the 3-minute Modified Schirmer Test (MST).
SecondarySalivary pH1, 3 and 6, 12, 24 and 36 months post RTSalivary pH assessed using pH test strips.
SecondaryQuality of life (QOL)6, 12 and 24 months post RTQuality of life assessed using the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-H\&N43).
SecondaryFinancial Toxicity18 months post RT
Financial toxicity assessed using the Financial Index of Toxicity (FIT) which evaluates financial strain, psychosocial impacts, and coping behaviors related to treatment-associated costs. Higher scores indicate greater financial toxicity (worse outcome), lower scores indicate less financial burden.
SecondaryHealth Utility1, 6 and 18 months post RT
Health utility assessed using the EuroQol 5-Dimension Questionnaire (EQ-5D) which assesses mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with higher scores indicating better health-related quality of life.
SecondaryHead and Neck Cancer Recurrence Rate2 years
Proportion of participants with recurrent head and neck cancer following treatment, comparing participants receiving Streptococcus salivarius strain SALI-10 plus standard of care with those receiving standard of care alone.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07883005/registered